News
Shares of Caris Life Sciences soared in their public debut Wednesday, as investors bought into the company’s business of ...
The biotech firm filed its IPO paperwork May 23 in a bid to boost its finances, noting there was "substantial doubt" about ...
Caris Life Sciences, an AI-driven precision oncology company, is targeting a $5.35 billion valuation in its U.S. initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results